Docetaxel Anhydrous Interactions

Brand names: Docetaxel

2 interactions on record

In vivo studies showed that the exposure of docetaxel increased 2.2-fold when it was coadministered with ketoconazole, a potent inhibitor of CYP3A4.

Source: FDA drug label - docetaxel anhydrous

Protease inhibitors, particularly ritonavir, may increase the exposure of docetaxel.

Source: FDA drug label - docetaxel anhydrous